Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 6,992 | 353 | 53 | 5,139 |
| Cost of Goods | N/A | N/A | 154 | 10 | 2,388 |
| Gross Profit | N/A | 6,992 | 199 | 43 | 2,751 |
| Operating Expenses | 9,393 | 9,028 | 5,936 | 10,780 | 16,684 |
| Operating Income | -9,393 | -2,036 | -5,583 | -10,727 | -13,545 |
| Interest Expense | 129 | 130 | 0 | 0 | 0 |
| Other Income | 1,308 | 1,627 | -773 | 1,941 | 942 |
| Pre-tax Income | -8,214 | -539 | -6,356 | -8,786 | -12,603 |
| Income Tax | 86 | 69 | 39 | 50 | 97 |
| Net Income Continuous | -8,300 | -608 | -6,395 | -8,836 | -12,700 |
| Net Income | $-8,300 | $-608 | $-6,395 | $-8,836 | $-12,700 |
| EPS Basic Total Ops | -0.31 | -0.02 | -0.22 | -0.34 | -0.48 |
| EPS Basic Continuous Ops | -0.31 | -0.02 | -0.22 | -0.34 | -0.48 |
| EPS Diluted Total Ops | -0.31 | -0.02 | -0.22 | -0.34 | -0.48 |
| EPS Diluted Continuous Ops | -0.31 | -0.02 | -0.22 | -0.34 | -0.48 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.02 | -0.24 | N/A | N/A |
| EBITDA(a) | $-9,940 | $-2,567 | $-6,586 | $-10,732 | $-13,667 |